[Role of peptide leukotrienes in monocrotaline-induced lung disease].

Monocrotaline (MCT) causes lung inflammation and right ventricular hypertrophy associated with lung vascular thickening in rats. We hypothesized that peptide leukotrienes play a role in MCT-induced lung disease, and examined the effect of ONO 1078, a specific antagonist of LTC4, D4 and E4 receptors on MCT-induced right ventricular hypertrophy and on lung vascular thickening. Next, we measured leukotriene C4 (LTC4) levels in the lung tissue of MCT-treated rats. Within 3 weeks after the injection MCT had caused an increase in the ratio of right ventricular weight to left ventricle+septum weight (RV/(LV+S)) and an increase in media wall thickness of the muscular arteries of the lung. In rats given both ONO 1078 and MCT, these changes were significantly less severe than in rats given MCT only. The LTC4 levels in MCT-treated rats were significantly higher than in saline-treated control rats. These results indicate that this antagonist of peptide leukotriene receptors inhibits right ventricular hypertrophy induced by MCT, and suggest a role for peptide leukotrienes in the inflammatory process that contributes to lung vascular remodeling in MCT-treated rats.

[1]  N. Voelkel,et al.  PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension. , 1991, Journal of applied physiology.

[2]  D. Wilson,et al.  Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats. , 1989, Microvascular research.

[3]  P. Cannon,et al.  Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. , 1986, The Journal of biological chemistry.

[4]  R. Ardaillou,et al.  Leukotriene C4 binds to human glomerular epithelial cells and promotes their proliferation in vitro. , 1985, The Journal of clinical investigation.

[5]  N. Voelkel,et al.  Actions of lipoxygenase metabolites in isolated rat lungs. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[6]  K. Austen,et al.  The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. , 1984, The Journal of clinical investigation.

[7]  N. Voelkel,et al.  Leukotriene E4 causes pulmonary vasoconstriction, not inhibited by meclofenamate. , 1983, Prostaglandins.

[8]  P. Sirois,et al.  Leukotriene transformation by guinea-pig lungs. , 1983, Prostaglandins, leukotrienes, and medicine.

[9]  I. Dauber,et al.  Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[10]  N. Voelkel,et al.  Nonimmunological production of leukotrienes induced by platelet-activating factor. , 1982, Science.

[11]  J. O'flaherty,et al.  Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. , 1982, The Journal of biological chemistry.

[12]  S. Dahlén,et al.  Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Reid,et al.  Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. , 1980, The American journal of physiology.

[14]  N. Voelkel,et al.  Chronic propranolol treatment blunts right ventricular hypertrophy in rats at high altitude. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.

[15]  T. Kobayashi,et al.  In vivo pharmacologic profile of ONO-1078: a potent, selective and orally active peptide leukotriene (LT) antagonist. , 1992, Japanese journal of pharmacology.

[16]  S. Kunkel,et al.  Leukotriene C4 binds to rat lung fibroblasts and stimulates collagen synthesis. , 1987, Advances in prostaglandin, thromboxane, and leukotriene research.

[17]  D. Heath,et al.  Crotalaria spectabilis: the pulmonary hypertension plant , 1969 .